SLA and intrahepatic cholangiocarcinoma: Co‐cultured SLA class I‐silenced ICC‐derived cells with anti‐SLA‐specific antibodies showed significantly (P < .001) decreased cytotoxicity levels (3188 ± 286 RLU) compared to the control NT cells (4236 ± 268 RLU; Figure 6A).